Literature DB >> 12804795

Neonatal hypoxia-ischemia reduces ganglioside, phospholipid and cholesterol contents in the rat hippocampus.

M Rosana Ramirez1, Francine Muraro, Daniel S Zylbersztejn, Cristiano R Abel, Nice S Arteni, Daniel Lavinsky, Carlos A Netto, Vera M T Trindade.   

Abstract

Hypoxia-ischemia is a common cause of neonatal brain damage producing serious impact on cerebral maturation. This report demonstrates that rats submitted to hypoxia-ischemia present a marked decrease in hippocampal gangliosides, phospholipids and cholesterol contents as from 7 days after the injury. Although chromatographic profiles of the different ganglioside species (GM1, GD1a, GD1b, and GT1b) from the hippocampus of hypoxic-ischemic hippocampi groups (HI) were apparently unaffected, as compared with controls, there were quantitative absolute reductions in HI. The phospholipid patterns were altered in HI as from the 14th to the 30th day after the injury, where phosphatidylcholine (PC) quantities were higher than phosphatidylethanolamine (PE); additionally, the cardiolipin band was detected only in hippocampi of control adult rats. In general, the absolute quantities of phospholipids were lower in HI than in correspondent controls since 7th day after the injury. Considering that reported effects were maintained, we suggest they express a late biochemical response triggered by the neonatal hypoxic-ischemic episode; the consequences would be cell death and a delay on brain development, expressed by a reduction on synaptogenesis and myelinogenesis processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12804795     DOI: 10.1016/s0168-0102(03)00100-7

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  8 in total

1.  Methylphenidate disrupts cytoskeletal homeostasis and reduces membrane-associated lipid content in juvenile rat hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; Helena Biasibetti-Brendler; Fernanda Silva Ferreira; Fernanda Dos Santos Petry; Vera Maria Treis Trindade; Regina Pessoa-Pureur; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2017-12-29       Impact factor: 3.584

2.  Cognitive outcomes after neonatal encephalopathy.

Authors:  Athina Pappas; Seetha Shankaran; Scott A McDonald; Betty R Vohr; Susan R Hintz; Richard A Ehrenkranz; Jon E Tyson; Kimberly Yolton; Abhik Das; Rebecca Bara; Jane Hammond; Rosemary D Higgins
Journal:  Pediatrics       Date:  2015-03       Impact factor: 7.124

3.  Ovariectomy enhances acetylcholinesterase activity but does not alter ganglioside content in cerebral cortex of female adult rats.

Authors:  Siomara C Monteiro; Francieli M Stefanello; Luciene P Vianna; Cristiane Matte; Jaqueline Barp; Adriane Belló-Klein; Vera M T Trindade; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

Review 4.  Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.

Authors:  A Frajewicki; Z Laštůvka; V Borbélyová; S Khan; K Jandová; K Janišová; J Otáhal; J Mysliveček; V Riljak
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

5.  Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxic-ischemic encephalopathy: A meta-analysis of randomized controlled trials.

Authors:  Lei Sheng; Zhaohui Li
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

Review 6.  Current and Emerging Therapies in the Management of Hypoxic Ischemic Encephalopathy in Neonates.

Authors:  Jayasree Nair; Vasantha H S Kumar
Journal:  Children (Basel)       Date:  2018-07-19

7.  Upregulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain.

Authors:  Fuxin Lu; Jun Zhu; Selena Guo; Brandon J Wong; Farid F Chehab; Donna M Ferriero; Xiangning Jiang
Journal:  Pediatr Res       Date:  2018-05-02       Impact factor: 3.756

Review 8.  Cholesterol metabolism and brain injury in neonatal encephalopathy.

Authors:  Amanda M Dave; Eric S Peeples
Journal:  Pediatr Res       Date:  2020-10-26       Impact factor: 3.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.